Skip to main content

Peer Review reports

From: Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

Original Submission
27 Nov 2018 Submitted Original manuscript
20 Jan 2019 Reviewed Reviewer Report - William Richard Mulley
28 Jan 2019 Reviewed Reviewer Report - Osama Ashry Ahmed Gheith
6 Mar 2019 Author responded Author comments - Kasia Sablik
Resubmission - Version 2
6 Mar 2019 Submitted Manuscript version 2
1 Apr 2019 Reviewed Reviewer Report - Osama Ashry Ahmed Gheith
9 Apr 2019 Reviewed Reviewer Report - William Richard Mulley
22 Apr 2019 Author responded Author comments - Kasia Sablik
Resubmission - Version 3
22 Apr 2019 Submitted Manuscript version 3
28 Apr 2019 Author responded Author comments - Kasia Sablik
Resubmission - Version 4
28 Apr 2019 Submitted Manuscript version 4
13 May 2019 Author responded Author comments - Kasia Sablik
Resubmission - Version 5
13 May 2019 Submitted Manuscript version 5
Publishing
15 May 2019 Editorially accepted
14 Jun 2019 Article published 10.1186/s12882-019-1385-z

You can find further information about peer review here.

Back to article page